CME

This activity is supported by an educational grant from Merck & Co, Inc.

What's Hot in Melanoma? Highlights from the HemONC Today Melanoma and Cutaneous Malignancies 2017 Meeting

What's Hot in Melanoma? Highlights from the HemONC Today Melanoma and Cutaneous Malignancies 2017 Meeting

This activity is supported by an educational grant from Merck & Co, Inc.

Overview

Author(s)/Faculty: Sanjiv S. Agarwala, MD; Michael A. Postow, MD ; Ryan J. Sullivan, MD
Source: Healio - Hematology/Oncology Education Lab
Type: LectureArticles/Items: 3
Release Date: 4/11/2017Expiration Date: 4/10/2018
Credit Type: CMENumber of Credits: 0.5
Cost: FreeProvider: Vindico Medical Education
The development and integration of targeted therapies, as well as immunotherapies, into clinical strategies for the management of advanced melanoma has revolutionized the current treatment paradigm. Ongoing research continues to define optimal strategies for the utilization of these therapies; patients who will be provided best benefit; and emerging novel therapies with the potential to further enhance clinical outcomes. This CME activity, recorded at the 2017 HemOnc Today Melanoma and Cutaneous Malignancies Annual Meeting, features an expert panel discussion of the latest concepts regarding the role of biomarkers, emerging agents, and clinical strategies for the optimal management of advanced melanoma.

CME Information

page 1 of 6